{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-125433","form_type":"8-K","ticker":"CVKD","cik":"0001937993","company_name":"Cadrenal Therapeutics, Inc.","filed_at":"2025-12-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.106089+00:00","generated_at":"2026-05-16T12:19:42.565605+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Cadrenal Therapeutics files prospectus supplement for up to $1.77M ATM offering","bullets":["Already sold $10,005,300 in shares under the existing ATM agreement since March 2024.","New tranche of up to $1,770,028 of common stock through H.C. Wainwright as sales agent.","Commission of 3.0% of gross proceeds payable to Wainwright for its services.","Offer made under existing effective S-3 registration statement filed March 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-125433","json":"https://secwatch.observer/filing/0001213900-25-125433.json","markdown":"https://secwatch.observer/filing/0001213900-25-125433.md","text":"https://secwatch.observer/filing/0001213900-25-125433.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1937993/000121390025125433/0001213900-25-125433-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1937993/000121390025125433/ea0270908-8k_cadrenal.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:19:42.565605+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}